MERRIMACK PHARMACEUTICALS

Codice
MACK
Risorse esterne
Opinione della community
Prezzo Variazione Volume
3.01 -1.63 €
(-35.13%)
1789421
P/E Obiettivo ad 1anno
0 9 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 27
Sell : 5

P18634 cfalco LucaMazzu91 Halsabo KING DEI BOVOLONI ghed maggieramon Ramiro Matteo Berci Simone Bonzanini

Commenti


Notizie

Drilling Down Into Merrimack Pharmaceuticals, Inc. (MACK ... - StockNewsJournal

Merrimack Pharmaceuticals, Inc. (MACK) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, ... Leggi

Merrimack Pharmaceuticals, Inc. (MACK) hit his 1-Year Low price on Jan 23, 2017 - TopChronicle

The share of Merrimack Pharmaceuticals, Inc. (MACK) currently has a value of $3.01 while the company's 52 week low is at $2.83, the shares dropped to the 52 week low on Jan 23, 2017. While the company's share hit the 52 week high on Apr 7, 2016 ...altro » Leggi

Stock Alert and Holding Pattern: Merrimack Pharmaceuticals Inc Stock Volatility Hits An Elevated Level - CML News

As a heads up, in the "Why This Matters" section at the end of this article on Merrimack Pharmaceuticals Inc (NASDAQ:MACK) , we're going to take a step back and show really clearly that there is actually a lot less "luck" in successful option trading ...altro » Leggi

Can the next move of Merrimack Pharmaceuticals, Inc. (MACK) be predicted? - The Oracle Examiner

Currently Merrimack Pharmaceuticals, Inc. (MACK) is showing beta of 1.85. This particular value of beta suggests that Merrimack Pharmaceuticals, Inc. (MACK) has historically moved 185% for every 100% move in the benchmark, based on price level. Leggi

The Case for and Against Merrimack Pharmaceuticals, Inc. (MACK) - StockNewsJournal

Merrimack Pharmaceuticals, Inc. (MACK) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $3.06, up from yesterday's close by 1.32%. Given the stock's recent ...altro » Leggi

The Tudor Investment Corp Et Al Takes Position in Merrimack Pharmaceuticals Inc (MACK) - Petro Global News 24

Tudor Investment Corp Et Al acquired a new position in Merrimack Pharmaceuticals Inc (NASDAQ:MACK) during the fourth quarter, Holdings Channel reports. The fund acquired 45,209 shares of the biopharmaceutical company's stock, valued at ... Leggi

Stocks Directions: Mast Therapeutics, Inc. (MSTX), Merrimack Pharmaceuticals, Inc. (MACK) - TWN

Merrimack Pharmaceuticals, Inc. (MACK) opened the session with a $3.05 price tag, later ranging from $2.99 to $3.082, the range at which the stock has traded at throughout the day. The stock stands nearly $5.97 off versus the 52-week high of $9.02 and ...altro » Leggi

The Finish Line, Inc. (FINL), Merrimack Pharmaceuticals, Inc. (MACK ... - The USA Commerce

The relative strength index or RSI highlights overbought (above 70) and oversold (below 30) areas. The current value of the RSI is 49.32 that is neither bought ... Leggi

Merrimack Pharmaceuticals, Inc.'s (MACK) stock price is Worth at ... - Hot Stocks Point

USA based company, Merrimack Pharmaceuticals, Inc. (MACK)'s latest closing price distance was at -36.10% from the average-price of 200 days while it ...altro » Leggi

Stocks Highlighted As Major Movers: Great Plains Energy ... - TWN

Great Plains Energy Incorporated (NYSE:GXP) shares ended at $28.87 with 2.73 mln shares exchanging hands. That puts the market capitalization at $6.2 bln.altro » Leggi